MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 7 (2010), Issue 6 (June)

1. One-stage revision for patients with a chronically infected reverse total shoulder replacement.
   J Bone Joint Surg Br, 92(6): 817-22. [Abstract] [Full-text]
2. Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls.
   Epidemiol Infect. [Abstract] [Full-text]
3. A miniature mimic of host defense peptides with systemic antibacterial efficacy.
   FASEB J, 24(6): 1904-13. [Abstract] [Full-text]
4. Device-associated infections in the intensive care units of Cyprus: results of the first national incidence study.
   Infection, 38(3): 165-71. [Abstract] [Full-text]
5. Multifocal community-acquired necrotizing fasciitis caused by a Panton-Valentine leukocidin-producing methicillin-sensitive Staphylococcus aureus.
   Infection, 38(3): 223-5. [Abstract] [Full-text]
6. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?
   Infection, 38(3): 159-64. [Abstract] [Full-text]
7. Blechnum orientale Linn - a fern with potential as antioxidant, anticancer and antibacterial agent.
   BMC Complement Altern Med, 10: 15. [Abstract] [Full-text]
8. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in dogs and cats: a case-control study.
   Vet Res, 41(5): 55. [Abstract] [Full-text]
9. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008.
   Pediatrics, 125(6): e1294-300. [Abstract] [Full-text]
10. Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
    Am J Health Syst Pharm, 67(12): 1017-24. [Abstract] [Full-text]
11. Ceftobiprole: A novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Am J Health Syst Pharm, 67(12): 983-93. [Abstract] [Full-text]
12. High prevalence of MRSA clone ST80-IV in the hospital and community settings in Algiers.
    Clin Microbiol Infect. [Abstract] [Full-text]
13. Comparative evaluation of five culture media with triplex PCR assay for detection of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 61(1): 1-6. [Abstract] [Full-text]
14. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers.
    Infect Control Hosp Epidemiol, 31(7): 716-21. [Abstract] [Full-text]
15. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.
    Bioorg Med Chem Lett, 20(12): 3518-20. [Abstract] [Full-text]
16. Charting the course for the future of science in healthcare epidemiology: results of a survey of the membership of the Society of Healthcare Epidemiology of America.
    Infect Control Hosp Epidemiol, 31(7): 669-75. [Abstract] [Full-text]
17. Identification and eradication of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: results of a national survey.
    Infect Control Hosp Epidemiol, 31(7): 766-8. [Abstract] [Full-text]
18. Antibiotic-loaded chitosan film for infection prevention: A preliminary in vitro characterization.
    J Biomed Mater Res B Appl Biomater, 94(1): 203-11. [Abstract] [Full-text]
19. Ag/SiO(x)C(y) plasma polymer coating for antimicrobial protection of fracture fixation devices.
    J Biomed Mater Res B Appl Biomater, 94(1): 196-202. [Abstract] [Full-text]
20. Beyond beta: lessons learned from implementation of the Department of Veterans Affairs Methicillin-Resistant Staphylococcus aureus Prevention Initiative.
    Infect Control Hosp Epidemiol, 31(7): 763-5. [Abstract] [Full-text]
21. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage.
    Scand J Infect Dis, 42(6): 455-60. [Abstract] [Full-text]
22. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
    J Infect Chemother, 16(3): 193-9. [Abstract] [Full-text]
23. Up against the wall.
    Nat Med, 16(6): 628-31. [Abstract] [Full-text]
24. Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure.
    Infect Control Hosp Epidemiol, 31(7): 701-9. [Abstract] [Full-text]
25. Pharmacological issues of linezolid: an updated critical review.
    Clin Pharmacokinet, 49(7): 439-47. [Abstract] [Full-text]
26. Methicillin resistant Staphylococcus aureus in a Japanese community hospital: 5-year experience.
    J Infect Chemother. [Abstract] [Full-text]
27. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.
    Graefes Arch Clin Exp Ophthalmol. [Abstract] [Full-text]
28. Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants.
    Microbes Infect, 12(6): 446-56. [Abstract] [Full-text]
29. Association between respiratory and herpes viruses on pulmonary exacerbations in cystic fibrosis patients.
    J Cyst Fibros, 9(3): 234-6. [Abstract] [Full-text]
30. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
    JAMA, 303(22): 2260-4. [Abstract] [Full-text]
31. Central nervous system infections in patients with severe burns.
    Burns, 36(5): 688-91. [Abstract] [Full-text]
32. Involvement of endotoxin in the mortality of mice with gut-derived sepsis due to methicillin-resistant Staphylococcus aureus.
    Microbiol Immunol, 54(6): 330-7. [Abstract] [Full-text]
33. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection.
    Microbiol Immunol, 54(5): 265-75. [Abstract] [Full-text]
34. The potential economic value of a Staphylococcus aureus vaccine for neonates.
    Vaccine, 28(29): 4653-60. [Abstract] [Full-text]
35. Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene.
    PLoS One, 5(6): e10990. [Abstract] [Full-text]
36. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus.
    Cell Host Microbe, 7(6): 463-73. [Abstract] [Full-text]
37. Direct detection of methicillin-resistant Staphylococcus aureus from blood cultures using an immunochromatographic immunoassay-based MRSA rapid kit for the detection of penicillin-binding protein 2a.
    Diagn Microbiol Infect Dis, 67(3): 301-3. [Abstract] [Full-text]
38. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Diagn Microbiol Infect Dis, 67(3): 228-33. [Abstract] [Full-text]
39. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America.
    Int J Infect Dis, 14(7): e560-6. [Abstract] [Full-text]
40. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.
    Curr Med Res Opin, 26(7): 1565-78. [Abstract] [Full-text]
41. Implementation of a hospital-wide project for appropriate antimicrobial prophylaxis.
    J Infect Chemother. [Abstract] [Full-text]
42. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.
    JAMA, 303(23): 2386-92. [Abstract] [Full-text]
43. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
    Pharmacoeconomics, 28(7): 567-75. [Abstract] [Full-text]
44. In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates.
    Antimicrob Agents Chemother, 54(7): 3027-30. [Abstract] [Full-text]
45. Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.
    Antimicrob Agents Chemother, 54(7): 2767-74. [Abstract] [Full-text]
46. Teicoplanin versus vancomycin for proven or suspected infection.
    Cochrane Database Syst Rev, 6: CD007022. [Abstract] [Full-text]
47. Inducibly cefoxitin resistant Macrococcus like organism falsely identified as MRSA on CHROMagar with oxacillin.
    J Clin Microbiol. [Abstract] [Full-text]
48. Epidemic meticillin-resistant Staphylococcus aureus (EMRSA-15) variants detected in healthy and diseased individuals in India.
    J Med Microbiol, 59: 815-21. [Abstract] [Full-text]
49. Relationship of Vancomycin MIC to Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia.
    Chest. [Abstract] [Full-text]
50. Endovascular repair of ascending aortic rupture: effectiveness of a fenestrated stent-graft.
    J Endovasc Ther, 17(3): 395-8. [Abstract] [Full-text]
51. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
    Interact Cardiovasc Thorac Surg, 11(1): 52-5. [Abstract] [Full-text]
52. Mini-bronchoalveolar lavage quantitative polymerase chain reaction for diagnosis of methicillin-resistant Staphylococcus aureus pneumonia.
    Crit Care Med, 38(7): 1536-41. [Abstract] [Full-text]
53. Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections.
    Epidemiol Infect. [Abstract] [Full-text]
54. Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates.
    Epidemiol Infect. [Abstract] [Full-text]
55. Methicillin-resistant coagulase-negative staphylococci in the community: high homology of SCCmec IVa between Staphylococcus epidermidis and major clones of methicillin-resistant Staphylococcus aureus.
    J Infect Dis, 202(2): 270-81. [Abstract] [Full-text]
56. Antibacterial constituents from the roots of Erythrina herbacea against methicillin-resistant Staphylococcus aureus.
    Planta Med, 76(9): 916-9. [Abstract] [Full-text]
57. Gram-positive occult bacteremia in patients with pacemaker and mechanical valve prosthesis: a difficult therapeutic challenge.
    Europace, 12(7): 999-1002. [Abstract] [Full-text]
58. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041.
    Eur J Clin Microbiol Infect Dis, 29(7): 771-7. [Abstract] [Full-text]
59. An independent in vitro comparison of povidone iodine and SteriLid.
    J Ocul Pharmacol Ther, 26(3): 277-80. [Abstract] [Full-text]
60. Viral colonization in intubated patients: initial pathogen pattern and follow-up.
    Clin Respir J, 4(3): 139-46. [Abstract] [Full-text]
61. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Clin Microbiol Infect, 16(6): 747-52. [Abstract] [Full-text]
62. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Clin Microbiol Infect, 16(6): 722-8. [Abstract] [Full-text]
63. Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia.
    Clin Microbiol Infect, 16(6): 575-82. [Abstract] [Full-text]
64. Active surveillance testing and decontamination strategies in intensive care units to reduce methicillin-resistant Staphylococcus aureus infections.
    Am J Infect Control, 38(5): 361-7. [Abstract] [Full-text]
65. Exposure of emergency medical responders to methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 38(5): 368-73. [Abstract] [Full-text]
66. Molecular characterization of Staphylococcus aureus isolates causing skin and soft tissue infections (SSTIs).
    BMC Infect Dis, 10: 133. [Abstract] [Full-text]
67. Community-based intervention to manage an outbreak of MRSA skin infections in a county jail.
    J Correct Health Care, 16(3): 205-15. [Abstract] [Full-text]
68. Tuberculosis control: lessons for outbreak preparedness in correctional facilities.
    J Correct Health Care, 16(3): 239-42. [Abstract] [Full-text]
69. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.
    BMC Infect Dis, 10: 159. [Abstract] [Full-text]
70. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania.
    BMC Pediatr, 10: 39. [Abstract] [Full-text]
71. Antimicrobial susceptibilities of Coagulase-Negative Staphylococci (CNS) and Streptococci from bovine subclinical mastitis cases.
    J Microbiol, 48(3): 267-74. [Abstract] [Full-text]
72. Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV.
    J Eur Acad Dermatol Venereol. [Abstract] [Full-text]
73. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
    Am J Infect Control, 38(5): S25-33. [Abstract] [Full-text]
74. A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute.
    J Artif Organs, 13(2): 101-5. [Abstract] [Full-text]
75. Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) on various environmental surfaces by mist application of a stabilized chlorine dioxide and quaternary ammonium compound-based disinfectant.
    J Occup Environ Hyg, 7(9): 529-34. [Abstract] [Full-text]
76. Survival of community-associated methicillin-resistant Staphylococcus aureus in 3 different swimming pool environments (chlorinated, saltwater, and biguanide nonchlorinated).
    Clin Pediatr (Phila), 49(7): 635-7. [Abstract] [Full-text]
77. Xanthogranulomatous Pyelonephritis in an Adolescent.
    Urology. [Abstract] [Full-text]
78. Diabetic foot infections: diagnosis and management.
    Surg Infect (Larchmt), 11(3): 295-8. [Abstract] [Full-text]
79. Clinical Outcomes by Methicillin-Resistant Staphylococcus aureus SCCmec Type: Isolates Recovered from a Phase IV Clinical Trial of Linezolid and Vancomycin for Complicated Skin and Skin Structure Infections.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
80. Development of Daptomycin Nonsusceptibility with Heterogeneous Vancomycin Intermediate Resistance and Oxacillin Susceptibility in Methicillin-Resistant Staphylococcus aureus during High-Dose Daptomycin Treatment.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
81. Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.
    J Clin Microbiol, 48(7): 2599-600. [Abstract] [Full-text]
82. Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ.
    J Am Chem Soc, 132(26): 9069-77. [Abstract] [Full-text]
83. Rapid Neutrophil Destruction following Phagocytosis of Staphylococcus aureus.
    J Innate Immun. [Abstract] [Full-text]
84. Longitudinal Investigation of Methicillin-Resistant Staphylococcus aureus in Piglets.
    Zoonoses Public Health. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.